Skip to content

Aquatic Group Exercise for People With Parkinson Disease

Comparison of Aquatic and Land-based Group Exercise for Individuals With Parkinson Disease

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04291027
Enrollment
5
Registered
2020-03-02
Start date
2020-02-28
Completion date
2020-03-10
Last updated
2021-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Brief summary

This study will investigate the impact of land based or aquatic based group exercise on the balance, walking, balance confidence, and quality of life of people with idiopathic Parkinson disease. Participants will be randomized to participate in a land based or aquatic based group exercise program 2 times per week for 12 weeks. Prior to and after participation, balance, walking, quality of life, and balance confidence will be measured by a blinded examiner.

Interventions

Group exercise intervention will be held 2 times per week for 12 weeks and will include balance training, strengthening, gait training, and cardiovascular training.

Group exercise intervention will be held 2 times per week for 12 weeks and will include balance training, strengthening, gait training, and cardiovascular training.

Sponsors

Parkinson's Foundation
CollaboratorOTHER
Ithaca College
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* adults over the age of 18 who have been diagnosed with idiopathic Parkinson disease. * stable dose of levadopa medication for 30 days prior to study initiation * able to walk 20 feet without physical assistance * a referral from a physician to participate in physical therapy

Exclusion criteria

individuals with: * uncontrolled cardiovascular or pulmonary conditions * deep vein thrombosis in the last 6 months * the use of breathing tube or feeding tube * those with an extreme fear of exercising in the water * an active dermatological condition (including eczema, psoriasis, or open wound) -any other neurological condition other than Parkinson disease * a musculoskeletal condition that would impact their ability to participate in the exercise group * cognitive impairment (a score of less than 24/30 on the Mini Mental Status Examination)

Design outcomes

Primary

MeasureTime frameDescription
Change in Gait SpeedPrior to intervention, after 12 week interventionThe 10 meter walk test will be examined at self selected and fast speeds to examine gait speed.
Change in Mini-BESTest ScorePrior to intervention, after 12 week interventionThe Mini-BESTest examines postural control. A higher scores means less balance impairment.
Change in Movement Disorder Society-Unified Parkinson Disease Rating Scale (MDS-UPDRS): Part IIIPrior to intervention, after 12 week interventionThe Movement Disorders Society-Unified Parkinson Disease Rating Scale examines motor function for people with Parkinson disease. A higher score indicates higher motor impairment related to Parkinson disease.

Secondary

MeasureTime frameDescription
Change in Parkinson Disease Questionnaire-39 (PDQ-39)Prior to intervention, after 12 week interventionThe Parkinson disease questionnaire-39 measures quality of life for people with Parkinson disease. A higher score means more quality of life limitations related to Parkinson disease.
Change in Falls Efficacy Scale-International.Prior to intervention, after 12 week interventionThe Falls Efficacy Scale-International measures a person's balance confidence. A higher score is related to worse balance confidence.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026